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Objective: Chronic opioid therapy may be associated with hyperalgesia. Our objective was 
to determine if opioid-induced hyperalgesia detection sensitivity is dependent on the stimulus 
used to detect it.
Methods: This open design study compared the detection of hyperalgesia in opioid-dependent 
subjects (n = 16) and healthy control subjects (n = 16) using the following pain stimuli: cold pain, 
electrical stimulation, mechanical pressure, and ischemic pain. The opioid-dependent subjects 
were maintained on either methadone (n = 8) or buprenorphine (n = 8) for at least 3 months. 
None of the controls was dependent on opioids or other drugs of abuse.
Results: The opioid-dependent subjects were markedly more sensitive than controls to the 
cold pain test. Compared with the control group, the hazard ratio for ceasing the test due to 
i  ntolerable pain was 7.7 (95% confidence interval [CI] 2.6–23.3) in the buprenorphine group 
and 4.5 (95% CI 1.7–15.6) in the methadone group, with similar data for the cold pain threshold. 
Of the remaining tests, there were differences only for the electrical pain threshold between 
  treatment groups, with the geometric mean threshold in the buprenorphine group being 1.5 
(95% CI 1.1–1.9)-fold higher (ie, less sensitive) than that of the controls; the geometric mean 
for the methadone group was 1.3 (95% CI 1.04–1.7)-fold higher than that of the controls. There 
were no significant differences between buprenorphine and methadone patients in test responses. 
Women were more sensitive to the cold pain (hazard ratio for tolerance, 3.1 [95% CI 1.4–7.3]) 
and ischemic tests (hazard ratio for tolerance, 2.7 [95% CI 1.2–6.1]). There were significant 
correlations between cold and ischemic tolerances (r = 0.50; P = 0.003) and between electrical 
and mechanical pain tolerances (r = 0.52; P = 0.002).
Conclusion: These findings indicate that cold pain is the most suitable of the methods tested 
to detect opioid-induced hyperalgesia. This is consistent with its sensitivity to detect opioid 
analgesia.
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Introduction
Continued reporting of pain despite escalating doses of opioids has been interpreted 
as being due to pharmacological tolerance. However, recent evidence and studies on 
former opioid addicts, patients undergoing surgery, and healthy subjects suggest that 
exposure to opioids results in an increased sensitivity to pain, a phenomenon referred to 
as opioid-induced hyperalgesia (OIH).1 This offers an alternative explanation for why 
patients chronically administered opioids require increasing doses to attain adequate 
levels of analgesia.2 There are no proven management strategies to help these patients, 
apart from opioid dose reduction, with which many are unable to comply.3,4
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To facilitate treatments for OIH, accurate detection 
and measurement of its presence are needed. Human 
experimental pain models can enable measurement of the 
characteristics of OIH using standard protocols. With this 
approach, an investigator can control the experimentally 
induced pain (nature, localization, intensity, frequency, and 
duration of the stimulus) and provide quantitative measures 
of psychophysical, behavioral, and/or neurophysiological 
responses.
Previous studies have shown that OIH is dependent 
on the nature of the pain model used. Chu et al2 assessed 
the development of tolerance and OIH in six patients with 
chronic lower back pain. Patients were assessed before and 
1 month after the commencement of oral morphine therapy. 
Cold pain and heat pain tests were used to measure pain 
sensitivity before and during a controlled infusion with 
remifentanil, a short-acting µ opioid agonist. All patients 
demonstrated an increase in sensitivity to experimental 
pain in relation to the cold pain test, showing reduced 
thresholds and tolerance, whereas OIH was not evident in 
the heat pain test.
Differences in the detection of OIH in relation to dif-
ferent pain induction methods were shown by Doverty 
et al.5 The nociceptive responses of methadone-maintained 
patients were compared to healthy control subjects. 
  Electrical stimulation and cold pain tests were used as noci-
ceptive stimuli. In the electrical stimulation test, methadone 
patients generally had a lower pain tolerance than controls 
at pre-dose, but had a higher tolerance 3-hours post-dose. 
With regard to the cold pain test, methadone patients were 
significantly less pain tolerant at both pre-dose and 3-hours 
post-dose.
Schall et al6 compared methadone patients with healthy 
controls using mechanical pressure induced pain. There was 
no substantial difference in pain threshold and tolerance 
between the groups; thus, OIH was not detected.
These results suggest that OIH is not consistently detected 
by all pain models, with the most sensitive and reliable test 
being cold pain. This is not necessarily a surprise. Using 
experimental pain models, detection of antinociception fol-
lowing opioid administration depends on the stimulus used.7 
Comparisons across studies may be misleading due to dif-
ferences in patient populations, investigator techniques, and 
sample size. It is also uncommon for studies of OIH to use 
more than one or two techniques. However, in this study, 
four experimental pain models are compared in terms of 
their ability to detect and measure OIH.
Materials and methods
Participants
Sixteen opioid-dependent patients (ODS) (mean age, 37.4 
years; range, 25–51 years) were enrolled. These included 
eight (four male and four female) methadone-maintained 
(mean dose, 85.25 mg; range, 35–150 mg) and eight (four 
male and four female) buprenorphine-maintained subjects 
(mean dose, 14.25 mg; range, 6–24 mg) who had been taking 
opioids for at least 3 months as part of an opioid substitution 
therapy program. Patients were recruited through an outpa-
tient clinic from Drug and Alcohol Services South Australia, 
Parkside, South Australia, Australia. ODS were excluded if 
they were also dependent on alcohol or other drugs of abuse, 
had conditions that were affected by sensitivity to cold, 
had taken any analgesics (except their maintenance opioid) 
24 hours prior to the study, or if they were suffering from 
chronic pain. A urine dipstick test (Microgenics,   Passau, 
Germany) was performed on each subject to test for the 
presence of opioids (other than methadone or buprenorphine) 
and other drugs of abuse (cannabinoids, benzodiazepines, 
cocaine, and amphetamines).
Sixteen gender-matched healthy control subjects 
(eight male and eight female; mean age, 22.9 years; range, 
18–37 years) were also recruited for the study from a healthy 
volunteer database. Control subjects were included if they 
were in good physical health and had no history of addic-
tion or chronic opioid use. Potential control subjects were 
excluded if they suffered from chronic pain, had taken 
any analgesics 24 hours prior to the study, or if they were 
dependent on alcohol or other drugs of abuse. They also had 
a urine dipstick test to check for the presence of opioids and 
other drugs of abuse.
Before admission into the trial, all subjects gave informed 
consent. Subjects were reimbursed for their participation 
upon completion of the study and were free to withdraw at 
any time. The study was carried out in accordance with the 
principles of the International Conference of   Harmonisation 
Good Clinical Practice, and was approved by the Royal 
Adelaide Hospital Research Ethics Committee, Adelaide, 
South Australia, Australia.
Study plan and design
Each subject was studied in one session, with each study 
session lasting for approximately two hours. All subjects 
had a brief familiarization session to accustom them to the 
e  xperimental procedures of the pain models prior to testing.
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Pupillometry was performed before the commence-
ment of testing. The tests were the cold pain test, electrical 
stimulation test, mechanical pressure test, and ischemic 
pain test. The pain tolerance and pain threshold for each test 
were measured. The order of the four pain tests was varied 
according to a balanced Latin square design to control for 
carry-over effects. The subject’s eyes were covered during 
all tests, and there was a 15-minute resting period between 
each pain test.
Upon completion of the testing schedule, the ODS took 
their usual dose of methadone or buprenorphine.
Cold pain test
The cold pain test was based on the procedures of Doverty 
et al.5 The test used two cylindrical temperature-controlled 
water baths (380 cm in depth, 300 cm in diameter) of 
34.5°C–35.5°C and 0.5°C–1.5°C. A water pump (Brolga 
MV 1500, Brolga Australia Pty Ltd, Haberfield, NSW, Aus-
tralia) was placed in the cold water bath to prevent laminar 
warming around the subject’s immersed limb. Each subject’s 
nondominant forearm and hand (fingers wide apart) were 
placed vertically into the warm water bath, controlled by a 
thermoregulator (Unistat 110, Thermoline Scientific, Syd-
ney, Australia) for exactly 2 minutes. After 1 minute and 
45 seconds, a blood pressure cuff was inflated to a pressure 
of 20 mmHg below their diastolic blood pressure. This was 
done to minimize the role of blood flow in determining the 
reaction to cold. At exactly 2 minutes, their forearm was 
placed into the cold water bath. To minimize distraction 
and time cues, the subject’s eyes were blindfolded for the 
entire procedure. Once the arm was immersed in the cold 
water bath, subjects indicated when they first experienced 
pain (pain threshold). They were asked to leave their arm 
submerged until they could no longer tolerate the pain (pain 
tolerance); the cut-off time limit was 180 seconds. Endpoints 
were measured as time (seconds).
Electrical stimulation test
The electrical stimulation test was based on the methods 
used by Doverty et al.5 A small amount of electrical contact 
gel (Livingstone International, Pty Ltd, Sydney, Australia) 
was applied to the subject’s earlobe to provide conductance 
between the skin and electrode. The skin electrode, which 
delivered the electrical pulses, was clipped to the subject’s 
ear. The subjects were blindfolded to minimize distraction. 
An electrical stimulator (Grass model SC6, Grass Instru-
ments, Quincy, MA) delivered electrical square wave pulses 
of 14 milliseconds duration (0.7 pulses/second). The voltage 
commenced at 0 (baseline) and increased at a constant rate 
of 2 volts every 1.4 seconds (to a maximum of 100 volts). 
Subjects were asked to indicate when they first felt a sensa-
tion, when they first detected pain, and when they could no 
longer tolerate the pain. Endpoints were measured in volts.
Mechanical pressure test
A pressure algometer (Force One FDI, Wagner, Greenwich, 
CT) was used to measure mechanical pain.8–11 The algo-
meter was pressed perpendicular to the skin above the thenar 
eminence (muscle on the palm of the hand, just beneath the 
thumb) on the nondominant hand of the subject. The pressure 
algometer was fixed on custom-made equipment adapted 
from a drill press, which allowed controlled and progressive 
force to be applied by the operator without fatigue. The force 
was increased at a fixed rate of 10 Newtons/10 seconds (to 
a maximum of 300 Newtons). Subjects indicated when they 
first felt pain and when they could no longer tolerate the pain-
ful stimulation. Endpoints were measured in Newtons.
ischemic pain test
The ischemic pain test was based on the methods by Plesan 
et al.12 A blood pressure cuff was placed around the non-
dominant arm of the subject. The cuff pressure was increased 
to 20 mmHg above the subject’s systolic pressure. With the 
pressure maintained, subjects performed a handgrip exercise 
on an elastic ball, in accordance to the rhythm of a metro-
nome (Wittner GmbH and Co, Isny im Allgäu, Germany). 
The subject’s eyes were covered for the entire procedure to 
minimize distraction and time cues. Subjects were then asked 
to indicate when they first detected the pain and when they 
could no longer tolerate the pain (to a maximum of 5 minutes). 
Once pain tolerance was reached, the blood pressure cuff was 
immediately deflated. Endpoints were measured in seconds.
Statistical analysis
Statistical analysis was performed using SAS (v 9.2; SAS 
Institute Inc, Cary, NC) and statistical significance was 
assumed at P , 0.05.
Differences in pain threshold and pain tolerance between 
drug groups and gender were assessed by Cox proportional 
hazards models for cold pain and ischemic pain and by two-
way analysis of variance models for mechanical pressure pain 
and electrical stimulation pain. Data analyzed by analysis of 
variance were log transformed prior to model fitting to satisfy 
model assumptions.
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Associations between measures of pain (threshold 
and   tolerance) for each pain stimulus were assessed by 
S  pearman’s correlation coefficients.
Results
Pain threshold and tolerance
Figure 1 shows the pain threshold and pain tolerance of the 
ODS and control subjects across the four pain models.
Cold pain test
There were significant treatment group differences in cold 
pain threshold and tolerance, with the opioid groups being 
more sensitive than the controls. For threshold, the hazard 
ratio for reporting pain was 6.8 (95% CI 2.2–20.6) in the 
buprenorphine group compared with control; for the metha-
done group, the hazard ratio compared with control was 
4.1 (95% CI 1.4–11.7). For tolerance, the hazard ratio for 
terminating the test due to intolerable pain was 7.7 (95% CI 
2.6–23.3) in the buprenorphine group compared with control; 
for the methadone group, the hazard ratio compared with 
control was 4.5 (95% CI 1.7–15.6).
Electrical pain test
There were significant treatment group differences in elec-
trical threshold but not tolerance, with higher thresholds in 
the opioid groups. For threshold, the geometric mean in the 
buprenorphine group was 1.5 (1.1–1.9)-fold that of control, 
and for the methadone group, the geometric mean was 1.3 
(95% CI 1.04–1.7)-fold that of control.
ischemic pain test and mechanical pain
There were no significant differences between treatment 
groups for either threshold or tolerance for ischemic and 
mechanical pain tests.
Correlation among pain tests
Correlations between thresholds and tolerances for each test 
are listed in Table 1. For each test, there was a moderate to 
high correlation between threshold and tolerance, as would 
be expected. There was a moderate correlation between 
cold pain and ischemic tolerances (r = 0.50, P = 0.003), 
and between electrical and mechanical tolerances (r = 0.52, 
P = 0.002) but other correlations were much weaker.
Gender differences
There was a significant gender difference apparent in the 
cold pain test, with the hazard ratio in women being 2.3 
(1.0–5.4) for threshold and 3.1 (1.4–7.3) for tolerance 
compared with men. For the ischemic test, the hazard ratio 
in women for threshold was 3.8 (1.5–9.6) and for tolerance 
was 2.7 (1.2–6.1) compared with men. For the mechanical 
pain test, there was no gender difference for threshold, but 
the tolerance was 1.4 (95% CI 1.05–1.83)-fold higher for 
women compared with men. There was no significant dif-
ference between genders for either threshold or tolerance in 
the electrical pain test.
Methadone versus buprenorphine 
subjects
There were no appreciable differences in responses between 
the buprenorphine and methadone groups.
Discussion
Our results demonstrated that the nature of the pain stimu-
lus is an important factor in detecting OIH across the pain 
modalities. Recently, Staahl and Drewes13 reviewed the 
literature on the use of experimental pain models to detect 
the effects of opioids in acute pain models and models of 
hyperalgesia (but not OIH). The relative sensitivity of each 
model is not easy to determine, as it requires comparison 
between studies using different sample sizes and techniques; 
however, the vast majority of publications used only one pain 
model and very few compared several. OIH has not been 
studied experimentally in detail and our findings indicate 
that cold pain is the most sensitive of the methods tested in 
detecting opioid-related hyperalgesia. This was evident by 
the marked increase in sensitivity to cold pain threshold and 
tolerance by the ODS compared with the controls. The only 
other difference detected was reduced sensitivity to electrical 
pain threshold but not tolerance.
Our findings are consistent with results from previous 
studies, demonstrating that different pain stimuli produce 
different magnitude and direction of changes in pain toler-
ance between healthy participants and opioid users. A study 
conducted by Doverty et al5 compared nociceptive responses 
between 16 methadone-maintained and 16 healthy control 
subjects using the electrical stimulation and cold pain models. 
Their findings support our results because the methadone-
maintained subjects had a lower tolerance to cold pain and a 
higher tolerance to electrical pain in comparison to controls; 
hence, demonstration of OIH is dependent on the test model. 
Compton et al14 compared the pain tolerance of 18 metha-
done, 18 buprenorphine, and 18 control subjects using the 
cold pain test. The opioid-maintained subjects were signifi-
cantly less tolerant to cold pain than controls, which is also 
consistent with our findings. However, Pud et al15 showed 
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that although opioid addicts had a shorter cold pain toler-
ance time than control subjects, consistent with our findings, 
they had a significantly higher threshold time, which is not 
consistent with our findings. A possible explanation for their 
higher threshold time could be that addicts may first try to 
deny the feelings of pain (high threshold), but once this is 
no longer possible, they react quickly, as confirmed by their 
low pain tolerance time.
Luginbuhl et al7 used five pain tests (electrical pain, cold 
pain, pressure pain, ischemic pain, and heat pain) to measure 
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Figure 1 Comparison of pain threshold and pain tolerance between control subjects (n = 16), methadone dependent subjects (n = 8), and buprenorphine dependent subjects (n = 8) 
among the four different pain modalities. (A–D) depict cold pain threshold, cold pain tolerance, ischemic pain threshold, and ischemic pain tolerance, respectively, using Kaplan–Meier 
survival curves. (E and F) represent the electrical stimulation threshold and tolerance and the mechanical pain threshold and tolerance, presented as the mean ± standard deviation.
Abbreviations: Meth, methadone-dependent subjects; Bup, buprenorphine-dependent subjects; C-TR, controls’ threshold; M-TR, methadone-dependent subjects’ threshold; B-TR, 
buprenorphine-dependent subjects’ threshold; C-TL, controls tolerance; M-TL, methadone-dependent subjects’ tolerance; B-TL, buprenorphine-dependent subjects’ tolerance.
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the analgesic effects of alfentanil in 14 healthy volunteers 
(seven placebo and seven receiving alfentanil). There was 
no significant drug effect on the ischemic pain and heat pain 
model, whereas a significant difference was detected between 
the electrical, cold, and pressure pain tests. Although this 
was using an acute pain test rather than one of OIH, these 
findings confirm our finding that the opioid effects in one 
pain test cannot be extrapolated to another.
Reznikov and colleagues10 found no significant difference 
in pain thresholds between opioid maintained patients and 
patients receiving non-opioid analgesics using the mechanical 
pressure test, which is also consistent with our findings.
Reasons for the discrepancies among the different out-
comes of the different pain models observed in the various 
studies can be attributed in part to the nature of the pain 
stimuli.
Cold pain is an example of a tonic pain model. The 
innocuous cool sensation and cold pain are mediated by 
two different types of primary afferent fibers:16 A-δ fibers 
mediate cold sensations and C-fibers mediate cold pain.13 
The combination of the A-δ and C-fiber activation results 
in aching pain.
As mentioned, the cold pain test appears to be highly 
sensitive in detecting opioid effects. However, it is not a uni-
versally sensitive pain model, as it does not detect the effects 
of the potent high-efficacy non-steroidal anti-inflammatory 
drug ketorolac.14
Although the cold pain model has good reliability and 
validity and effectively mimics chronic pain conditions due 
to its unpleasantness, small variations in water temperature 
(as little as 2°C) can result in a significantly different pain 
experience.17 This methodological problem could explain 
some of the quantitative differences in the pain threshold 
and tolerance results, but should not affect the direction of 
the change.
Electrical stimulation is an example of a phasic pain 
model. An advantage of this stimulus is that it directly acti-
vates nerve fibers instead of specific nociceptor   activation.13 
Unlike the other three tests, which were applied to the upper 
limb, in this study, we used the earlobe site to be consistent 
with Doverty et al.5 Although this might affect the magnitude 
of the effect, we think that it is unlikely to be the reason for 
the ODS having higher threshold and tolerance than the 
controls, compared with the cold pain test in which the direc-
tion of difference was reduced. However, this is a potential 
factor in the observed higher tolerance in the ODS in this 
test compared with the others and future work should also 
include a similar test in the upper limb.
The mechanical pressure stimulus activates sensitive 
mechanoreceptors, myelinated A-δ fibers, and unmyelinated 
C-fibers, which mediate a dull, aching pain. It is experi-
mentally equivalent to palpations in the clinical setting.18 
A limitation of the mechanical pressure model is that the 
stimulus is not specific. Non-specific receptors in skin 
and deep tissue are activated along with non-nociceptors, 
which could have an inhibitory effect on pain perception. 
  Additionally, when mechanical pressure is truly nociceptive, 
it is likely to produce tissue damage.13 Mechanical stimulation 
Table 1 Correlations between models
Cold  
threshold
Cold  
tolerance
Ischemic  
threshold
Ischemic  
tolerance
Mechanical  
threshold
Mechanical  
tolerance
Electrical  
threshold
Electrical   
tolerance
Spearman correlation coefficients (n = 32)
Cold threshold 1.00 0.58 
0.0005
0.11 
0.53
0.09 
0.62
0.37 
0.04
0.22 
0.22
0.07 
0.72
–0.10 
0.60
Cold tolerance 0.58 
0.0005
1.00 0.46 
0.009
0.50 
0.003
0.31 
0.09
0.38 
0.03
-0.25 
0.16
0.18 
0.33
ischemic threshold 0.11 
0.53
0.46 
0.009
1.00 0.57 
0.0006
-0.02 
0.93
0.21 
0.25
-0.25 
0.16
0.16 
0.39
ischemic tolerance 0.09 
0.62
0.50 
0.003
0.57 
0.0006
1.00 0.19 
0.30
0.34 
0.05
-0.22 
0.22
0.19 
0.30
Mechanical threshold 0.37 
0.038
0.31 
0.09
-0.016 
0.93
0.19 
0.30
1.00 0.80 
,0.0001
0.28 
0.11
0.43 
0.01
Mechanical tolerance 0.23 
0.22
0.38 
0.03
0.21 
0.25
0.34 
0.05
0.80 
,0.0001
1.00 0.21 
0.25
0.52 
0.002
Electrical threshold 0.066 
0.72
-0.25 
0.16
-0.25 
0.16
-0.22 
0.22
0.28 
0.11
0.21 
0.25
1.00 0.56 
0.0009
Electrical tolerance -0.098 
0.60
0.18 
0.33
0.16 
0.39
0.19 
0.30
0.43 
0.01
0.52 
0.002
0.56 
0.0009
1.00
Note: in each cell, the upper figure is the Spearman rho and the lower figure the P value.
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can also be tonic (squeezing) or phasic (impact). Therefore, 
the use of either tonic or phasic mechanical stimuli could 
lead to variations in results.
Ischemic pain is a form of tonic muscle pain. It is acti-
vated by a combination of A-δ and C nociceptors from deep 
tissues.19 A limitation of this model is that although it induces 
pain in muscles, it is non-specific since it activates skin and 
other tissues, contributing to the pain experience. In addition 
to activating nociceptors, the contact of the tourniquet on the 
skin can also activate low threshold non-nociceptive nerves, 
which can exert an inhibitory effect on pain mechanisms. This 
model has not been used extensively with opioids.13
In addition to differing OIH detection sensitivities, the 
results from the four tests showed weak correlation, except 
for correlation between cold pain and ischemic tolerances 
and between electrical and mechanical tolerances. Other 
authors have also found relatively weak correlation between 
pain tests. For example, Fillinghim and colleagues20 found 
that analgesic responses in women using heat pain correlated 
with ischemic and pressure pain. However, Bhalang et al8 
showed a weak correlation between ischemic pain and heat 
with pressure pain. Similarly, Hastie et al9 found that cor-
relations across pain stimuli were weak when multiple tests 
were conducted in the same individual. These studies, along 
with our data, show that findings from one test cannot be 
extrapolated to another, and most importantly, that absence 
of an effect cannot be concluded from one pain model.
Women were more sensitive to cold pain and ischemic 
pain. Gender differences in experimental pain sensitivity 
have been found in previous studies.9,17,19,21,22 Gender differ-
ences between pain tolerance may be due to women having 
higher levels of anxiety associated with experimental pain in 
comparison to clinical pain.20 The gender of the investigator 
inflicting the pain is an additional factor.17 A study by   Gijsbers 
and N  icholson23 demonstrated that males had a higher pain 
threshold when tested by a female investigator than by a male 
investigator, whereas there was no difference in the pain 
thresholds of female subjects regardless of the gender of the 
investigator. This conclusion further supports earlier research 
conducted by Kallai et al24 and Levine and De Simone.25 In 
our study, we only had one female investigator, so subject–
investigator gender differences could not be concluded.
We selected patients receiving opioid substitution therapy 
rather than pain patients receiving opioids for this study to 
avoid the potential confounding effects of the pain states on 
  hyperalgesia. One additional factor to consider in the interpreta-
tion of this study is that the mean age of ODS participants was 14 
years older than the controls. There is no suitable information in 
the literature on whether an age difference of this size affects the 
test results. However, the primary objective was to compare the 
ability of the tests to differentiate between the groups. The obser-
vation that one test did this well (cold pain) and the others did 
not supports the design and conclusions of the study.
Our results also showed that methadone- and b  uprenorphine-
maintained subjects were equally   hyperalgesic. This was 
  supported by Compton et al,14 who found no significant 
difference in cold pain tolerance times between methadone-
maintained and buprenorphine-maintained subjects.
As hypothesized, the sensitivity of pain models in 
detecting OIH varied between the different methods due 
to the nature of the nociceptive stimulus. These findings 
indicate that the cold pain test is the most effective pain 
model in detecting OIH and should be the preferred model 
in research studies investigating OIH. Furthermore, subject 
gender and/or subject–investigator gender match/mismatch 
must be considered as important factors in the design of 
future experimental pain studies.
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